Companion Diagnostics

Companion Diagnostics

Global Companion Diagnostics Market to Reach $9.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Companion Diagnostics estimated at US$3.4 Billion in the year 2020, is projected to reach a revised size of US$9.2 Billion by 2027, growing at aCAGR of 15.1% over the period 2020-2027. Assay kits & Reagents, one of the segments analyzed in the report, is projected to record 14.3% CAGR and reach US$6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software & Services segment is readjusted to a revised 16.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1 Billion, While China is Forecast to Grow at 14.6% CAGR

The Companion Diagnostics market in the U.S. is estimated at US$1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 14.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.5% and 13% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.1% CAGR.We bring years of research experience to this 18th edition of our report. The 248-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Molecular
  • Agilent Technologies, Inc.
  • bioMérieux SA
  • Cepheid
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Foundation Medicine Inc.
  • Laboratory Corporation of America® Holdings
  • Leica Biosystems Nussloch GmbH
  • Merck & Co. Inc.
  • Myriad Genetics Inc.
  • NeoGenomics Laboratories, Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Inc.
  • Thermo Fischer Scientific Inc.


Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Companion Diagnostics: An Introductory Prelude
Quashing the One-Size-Fits-All Approach, CDx Wield Great Promise for Streamlined Drug Discovery & Development
Broader Scope and Applications Rev Up Growth Opportunities
Healthy Growth Projected over the Next Few Years
Developed Regions: Key Revenue Contributors
Market Witnesses Fast Paced Growth in Developing Regions
Northbound Trajectory in R&D Spending Creates Conducive Environment
Prevailing Economic Scenario Favors Funding Pattern
Global Competitor Market Shares
Companion Diagnostics Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Significance of Personalized Medicine Remains a Major Market Driver
Emphasis on Improving Targeted Therapies with CDx Tests Steers Momentum
Herceptin Lays the Road for Companion Diagnostics
Oncology - Dominant Therapy Area for CDx
Rising Incidence of Cancer Propels the Need for CDx Tests
Technology Advancements to Widen CDx Use Case
PCR: Dominant Technology Type for CDx Testing
Next-Generation Sequencing (NGS) Gains Widespread Traction in CDx Testing
Significant Role of Biomarkers in Companion Diagnostics
Critical Healthcare Needs of Aging Population Underpin CDx Sales
Regulatory Scenario Favors CDx Market
Resolving Prevailing Challenges: Critical for Future Growth of CDx Market
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Companion Diagnostics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 2: Companion Diagnostics Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
TABLE 3: Assay kits & Reagents (Product & Service) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 4: Assay kits & Reagents (Product & Service) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
TABLE 5: Software & Services (Product & Service) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
TABLE 6: Software & Services (Product & Service) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
TABLE 7: Polymerase Chain Reaction (PCR) (Technology) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
TABLE 8: Polymerase Chain Reaction (PCR) (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
TABLE 9: Immunohistochemistry (IHC) (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
TABLE 10: Immunohistochemistry (IHC) (Technology) Market Share Breakdown by Region/Country: 2020 VS 2027
TABLE 11: In Situ Hybridization (ISH) (Technology) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 12: In Situ Hybridization (ISH) (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
TABLE 13: Next-Generation Sequencing (NGS) (Technology) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
TABLE 14: Next-Generation Sequencing (NGS) (Technology) Market Percentage Share Distribution by Region/Country: 2020 VS 2027
TABLE 15: Other Technologies (Technology) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027
TABLE 16: Other Technologies (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
TABLE 17: Oncology (Indication) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 18: Oncology (Indication) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
TABLE 19: Neurology (Indication) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
TABLE 20: Neurology (Indication) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
TABLE 21: Other Indications (Indication) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
TABLE 22: Other Indications (Indication) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
TABLE 23: Pharmaceutical & Biopharmaceutical Companies (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 24: Pharmaceutical & Biopharmaceutical Companies (End-Use) Distribution of Global Sales by Region/Country: 2020 VS 2027
TABLE 25: Reference Laboratories (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
TABLE 26: Reference Laboratories (End-Use) Global Market Share Distribution by Region/Country for 2020 and 2027
TABLE 27: CROs (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
TABLE 28: CROs (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2020 VS 2027
TABLE 29: Other End-Uses (End-Use) Worldwide Sales in US$ Million by Region/Country: 2020-2027
TABLE 30: Other End-Uses (End-Use) Market Share Shift across Key Geographies: 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Companion Diagnostics Market Share (in %) by Company: 2018 & 2025
Market Analytics
TABLE 31: United States Companion Diagnostics Market Estimates and Projections in US$ Million by Product & Service: 2020 to 2027
TABLE 32: United States Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS 2027
TABLE 33: Companion Diagnostics Market in US$ Million in the United States by Technology: 2020-2027
TABLE 34: United States Companion Diagnostics Market Share Breakdown by Technology: 2020 VS 2027
TABLE 35: United States Companion Diagnostics Market Estimates and Projections in US$ Million by Indication: 2020 to 2027
TABLE 36: United States Companion Diagnostics Market Share Breakdown by Indication: 2020 VS 2027
TABLE 37: United States Companion Diagnostics Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
TABLE 38: Companion Diagnostics Market Share Breakdown in the United States by End-Use: 2020 VS 2027
CANADA
TABLE 39: Canadian Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020 to 2027
TABLE 40: Companion Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Product & Service for 2020 and 2027
TABLE 41: Companion Diagnostics Market Analysis in Canada in US$ Million by Technology: 2020-2027
TABLE 42: Canadian Companion Diagnostics Market Share Breakdown by Technology: 2020 VS 2027
TABLE 43: Canadian Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020 to 2027
TABLE 44: Companion Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Indication for 2020 and 2027
TABLE 45: Canadian Companion Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
TABLE 46: Canadian Companion Diagnostics Market Share Analysis by End-Use: 2020 VS 2027
JAPAN
TABLE 47: Japanese Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product & Service for the Period 2020-2027
TABLE 48: Japanese Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS 2027
TABLE 49: Japanese Medium & Long-Term Outlook for Companion Diagnostics Market in US$ Million by Technology: 2020-2027
TABLE 50: Japanese Companion Diagnostics Market Percentage Share Distribution by Technology: 2020 VS 2027
TABLE 51: Japanese Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2020-2027
TABLE 52: Japanese Companion Diagnostics Market Share Analysis by Indication: 2020 VS 2027
TABLE 53: Japanese Demand Estimates and Forecasts for Companion Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 54: Companion Diagnostics Market Share Shift in Japan by End-Use: 2020 VS 2027
CHINA
TABLE 55: Chinese Companion Diagnostics Market Growth Prospects in US$ Million by Product & Service for the Period 2020-2027
TABLE 56: Chinese Companion Diagnostics Market by Product & Service: Percentage Breakdown of Sales for 2020 and 2027
TABLE 57: Companion Diagnostics Market Estimates and Forecasts in China in US$ Million by Technology: 2020-2027
TABLE 58: Companion Diagnostics Market in China: Percentage Share Analysis by Technology for 2020 and 2027
TABLE 59: Chinese Companion Diagnostics Market Growth Prospects in US$ Million by Indication for the Period 2020-2027
TABLE 60: Chinese Companion Diagnostics Market by Indication: Percentage Breakdown of Sales for 2020 and 2027
TABLE 61: Chinese Demand for Companion Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 62: Chinese Companion Diagnostics Market Share Breakdown by End-Use: 2020 VS 2027
EUROPE
Market Facts & Figures
European Companion Diagnostics Market: Competitor Market Share Scenario (in %) for 2018 & 2025
Market Analytics
TABLE 63: European Companion Diagnostics Market Demand Scenario in US$ Million by Region/Country: 2018-2025
TABLE 64: European Companion Diagnostics Market Share Shift by Region/Country: 2020 VS 2027
TABLE 65: European Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020-2027
TABLE 66: European Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS 2027
TABLE 67: European Companion Diagnostics Market Assessment in US$ Million by Technology: 2020-2027
TABLE 68: Companion Diagnostics Market in Europe: Percentage Breakdown of Sales by Technology for 2020 and 2027
TABLE 69: European Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020-2027
TABLE 70: European Companion Diagnostics Market Share Breakdown by Indication: 2020 VS 2027
TABLE 71: European Companion Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
TABLE 72: European Companion Diagnostics Market Share Analysis by End-Use: 2020 VS 2027
FRANCE
TABLE 73: Companion Diagnostics Market in France by Product & Service: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 74: French Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS 2027
TABLE 75: French Companion Diagnostics Market Estimates and Projections in US$ Million by Technology: 2020-2027
TABLE 76: French Companion Diagnostics Market Share Breakdown by Technology: 2020 VS 2027
TABLE 77: Companion Diagnostics Market in France by Indication: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 78: French Companion Diagnostics Market Share Analysis by Indication: 2020 VS 2027
TABLE 79: Companion Diagnostics Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027
TABLE 80: French Companion Diagnostics Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
GERMANY
TABLE 81: Companion Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product & Service for the Period 2020-2027
TABLE 82: German Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS 2027
TABLE 83: German Companion Diagnostics Latent Demand Forecasts in US$ Million by Technology: 2020-2027
TABLE 84: German Companion Diagnostics Market Share Breakdown by Technology: 2020 VS 2027
TABLE 85: Companion Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2020-2027
TABLE 86: German Companion Diagnostics Market Share Breakdown by Indication: 2020 VS 2027
TABLE 87: Companion Diagnostics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
TABLE 88: Companion Diagnostics Market Share Distribution in Germany by End-Use: 2020 VS 2027
ITALY
TABLE 89: Italian Companion Diagnostics Market Growth Prospects in US$ Million by Product & Service for the Period 2020-2027
TABLE 90: Italian Companion Diagnostics Market by Product & Service: Percentage Breakdown of Sales for 2020 and 2027
TABLE 91: Companion Diagnostics Market Estimates and Forecasts in Italy in US$ Million by Technology: 2020-2027
TABLE 92: Companion Diagnostics Market in Italy: Percentage Share Analysis by Technology for 2020 and 2027
TABLE 93: Italian Companion Diagnostics Market Growth Prospects in US$ Million by Indication for the Period 2020-2027
TABLE 94: Italian Companion Diagnostics Market by Indication: Percentage Breakdown of Sales for 2020 and 2027
TABLE 95: Italian Demand for Companion Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 96: Italian Companion Diagnostics Market Share Breakdown by End-Use: 2020 VS 2027
UNITED KINGDOM
TABLE 97: United Kingdom Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Product & Service for the Period 2020-2027
TABLE 98: United Kingdom Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS 2027
TABLE 99: United Kingdom Medium & Long-Term Outlook for Companion Diagnostics Market in US$ Million by Technology: 2020-2027
TABLE 100: United Kingdom Companion Diagnostics Market Percentage Share Distribution by Technology: 2020 VS 2027
TABLE 101: United Kingdom Market for Companion Diagnostics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2020-2027
TABLE 102: United Kingdom Companion Diagnostics Market Share Analysis by Indication: 2020 VS 2027
TABLE 103: United Kingdom Demand Estimates and Forecasts for Companion Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 104: Companion Diagnostics Market Share Shift in the United Kingdom by End-Use: 2020 VS 2027
REST OF EUROPE
TABLE 105: Rest of Europe Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020-2027
TABLE 106: Rest of Europe Companion Diagnostics Market Share Breakdown by Product & Service: 2020 VS 2027
TABLE 107: Rest of Europe Companion Diagnostics Market Assessment in US$ Million by Technology: 2020-2027
TABLE 108: Companion Diagnostics Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2020 and 2027
TABLE 109: Rest of Europe Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020-2027
TABLE 110: Rest of Europe Companion Diagnostics Market Share Breakdown by Indication: 2020 VS 2027
TABLE 111: Rest of Europe Companion Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
TABLE 112: Rest of Europe Companion Diagnostics Market Share Analysis by End-Use: 2020 VS 2027
ASIA-PACIFIC
TABLE 113: Companion Diagnostics Market in Asia-Pacific by Product & Service: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 114: Asia-Pacific Companion Diagnostics Market Share Analysis by Product & Service: 2020 VS 2027
TABLE 115: Asia-Pacific Companion Diagnostics Market Estimates and Projections in US$ Million by Technology: 2020-2027
TABLE 116: Asia-Pacific Companion Diagnostics Historic Market Analysis in US$ Million by Technology: 2020 VS 2027
TABLE 117: Companion Diagnostics Market in Asia-Pacific by Indication: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 118: Asia-Pacific Companion Diagnostics Market Share Analysis by Indication: 2020 VS 2027
TABLE 119: Companion Diagnostics Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027
TABLE 120: Asia-Pacific Companion Diagnostics Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
REST OF WORLD
TABLE 121: Rest of World Companion Diagnostics Market Estimates and Forecasts in US$ Million by Product & Service: 2020 to 2027
TABLE 122: Companion Diagnostics Market in Rest of World: Percentage Share Breakdown of Sales by Product & Service for 2020 and 2027
TABLE 123: Companion Diagnostics Market Analysis in Rest of World in US$ Million by Technology: 2020-2027
TABLE 124: Rest of World Companion Diagnostics Market Share Breakdown by Technology: 2020 VS 2027
TABLE 125: Rest of World Companion Diagnostics Market Estimates and Forecasts in US$ Million by Indication: 2020 to 2027
TABLE 126: Companion Diagnostics Market in Rest of World: Percentage Share Breakdown of Sales by Indication for 2020 and 2027
TABLE 127: Rest of World Companion Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
TABLE 128: Rest of World Companion Diagnostics Market Share Analysis by End-Use: 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 80

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook